Page 3 - Knowledge Ecology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Yves here. Aside from Bill Gates’ unsavory role in defending the right of Big Pharma to rake in profits at the expense of the public during a massive public health crisis, there is also the wee problem of determining what selling a vaccine at cost would amount to. As a client put it, pointing to a conference room chair, “What does that chair cost? I can make it cost whatever I want to.” Specifically, big companies have considerable latitude as to the costs and overheads they allocate to products and businesses (that’s one reason they regularly have to call in McKinsey, the internal pr...

Covid-19 pandemic Friday 8 January 2021, by Sharon Lerner Pfizer CEO Albert Bourla recently heaped praise on “the almost 44,000 people who selflessly raised their hands to participate in our trial.” “Each of you has helped to bring the world one step closer to our shared goal of a potential vaccine to fight this devastating pandemic,” Bourla wrote in an open letter to volunteers who took part in Pfizer’s Covid-19 vaccine research, which was conducted in Argentina, South Africa, Brazil, Germany, and Turkey as well as the U.S. His letter was published on November 9, the same day Pfiz...

Boxes containing the Moderna Covid-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch on Dec. 20, 2020 in Olive Branch, Miss.Photo: Paul Sancya/Pool/Getty ImagesBoxes containing the Moderna Covid-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch on Dec. 20, 2020 in Olive Branch, Miss.Photo: Paul Sancya/Pool/Getty Images World Faces Covid-19 “Vaccine Apartheid” Even countries that hosted vaccine trials — like Argentina, South Africa, Brazil, and Turkey — will not receive adequate supplies. Decemb...

A Pfizer board member says the government declined to buy more doses beyond the initial 100 million already agreed upon. Demand from other countries could complicate future purchases.

Liam McBurney/Bloomberg via Getty Images hide caption toggle caption Liam McBurney/Bloomberg via Getty Images A vial of the COVID-19 vaccine developed by Pfizer and BioNTech that was used at the Royal Victoria Hospital in Belfast, U.K., on Tuesday. Liam McBurney/Bloomberg via Getty Images With Pfizer's COVID-19 vaccine poised for Food and Drug Administration authorization for emergency use, there's speculation about when the United States will buy another batch of doses — and whether the Trump administration already missed its chance. Although a Pfize...